Endoscopic resection is effective for the treatment of bleeding gastric hyperplastic polyps in patients with and without cirrhosis

Background and study aims: Gastric hyperplastic polyps (GHP) have been identified as a cause of transfusion-dependent iron-deficiency anemia (tIDA) and transfusion-dependent gastrointestinal bleeding and are commonly identified in the setting of cirrhosis. The aim of this study was to assess the effectiveness of endoscopic resection (ER) for the treatment of tIDA or gastrointestinal bleeding due to GHP in patients with and without liver disease.

Patients and methods: This was a single-center retrospective review. The primary outcome was clinical success of ER (no transfusion or repeat ER in the following 6 months after first ER). Secondary outcomes included technical success, recurrence of GHP with tIDA or gastrointestinal bleeding, and adverse events (AEs).

Results: Sixty-three patients with GHP were included of whom 20 (31 %) had cirrhosis. The majority with cirrhosis presented with gastrointestinal bleeding (n = 13, 65 %, P = 0.52), whereas the majority of non-cirrhotics presented with tIDA (n = 30, 70 %, P = 0.01). Technical success was 100 % with no AEs. The clinical success rate was 94 % (95 % in cirrhotics, 93 % in non-cirrhotics, P = 0.46). The recurrence rate was 32 % (40 % in cirrhotics and 28 % in non-cirrhotics, P = 0.35) with mean time to recurrence of 17.3 ± 13.9 months (P = 0.22). Of those with recurrence, 75 % had no further tIDA or gastrointestinal bleeding after repeat ER (mean follow-up 20 ±11 months).

Conclusions: ER is an effective treatment for GHP that causes tIDA or gastrointestinal bleeding. Patients with GHP and cirrhosis tend to present with bleeding rather than anemia and have more frequent recurrence. Symptomatic recurrence of GHP is common and should be recognized early as repeat ER appears to be effective.

• References

• 1 Carmack SW, Genta RM, Schuler CM et al. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol 2009; 104: 1524-1532
• 2 Sonnenberg A, Genta RM. Prevalence of benign gastric polyps in a large pathology database. Digest Liver Dis 2015; 47: 164-169
• 3 Jain R, Chetty R. Gastric hyperplastic polyps: a review. Dig Dis Sci 2009; 54: 1839-1846
• 4 Enestvedt BK, Chandrasekhara V, Ginsberg GG. Endoscopic ultrasonographic assessment of gastric polyps and endoscopic mucosal resection. Curr Gastroenterolog Rep 2012; 14: 497-503
• 5 Carmack SW, Genta RM, Graham DY et al. Management of gastric polyps: a pathology-based guide for gastroenterologists. Nature Rev Gastroenterol Hepatol 2009; 6: 331-341
• 6 Al-Haddad M, Ward EM, Bouras EP et al. Hyperplastic polyps of the gastric antrum in patients with gastrointestinal blood loss. Dig Dis Sci 2007; 52: 105-109
• 7 De Lisi S, Peralta S, Arini A et al. Oesophagogastroduodenoscopy in patients with cirrhosis: Extending the range of detection beyond portal hypertension. Dig Liver Dis 2011; 43: 48-53
• 8 Lam MC, Tha S, Owen D et al. Gastric polyps in patients with portal hypertension. Eur J Gastroenterol Hepatol 2011; 23: 1245-1249
• 9 Hirota WK, Zuckerman MJ, Adler DG et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006; 63: 570-580
• 10 Goddard AF, Badreldin R, Pritchard DM et al. The management of gastric polyps. Gut 2010; 59: 1270-1276
• 11 Amarapurkar AD, Amarapurkar D, Choksi M et al. Portal hypertensive polyps: distinct entity. Indian J Gastroenterol 2013; 32: 195-199
• Pai CG. Portal hypertensive polyp -- what is in a name?. Indian J Gastroenterol 2013; 32: 163-164